Passive Heymann nephritis (pHN) is an experimental rat model for human membranous glomerulopathy. In pHN, the formation of subepithelial immune deposits (ID) involves as antigenic targets the membrane glycoprotein gp330/megalin and the 44-kD receptor-associated protein (RAP). A single binding site for ID-inducing antibodies (Abs) was previously mapped to the 86 NH2-terminal amino acids of RAP (P,_AP>86). To further narrow this epitope, Abs eluted from the glomeruli were immunoblotted on membranes that were loaded with overlapping synthetic peptides representing the amino acid sequence of RAP (SPOTs system). Two adjacent Ab-binding domains with the sequences PVRLAE (amino acids 39-44) and HSD-LKIQE (amino acids 46-53), which were separated by a single L residue at amino acid 45, were detected. Rabbit Abs raised against synthetic peptides containing these domains individually (P31-44 and P46-53) failed to produce glomerular IDs. By contrast, Abs raised against a larger composite peptide (P31-53) induced IDs within 3 d that were firmly cross-linked to the glomerular basement membrane. These data suggest that Ab binding in vivo depends on the conformation of the antigenic target sequence that is preserved in the synthetic peptide P31-53, which covers the entire Ab-binding domain of RAP but not in its subdomains, P31-44 and P46-53. Collectively, these results locate the sole ID-inducing epitope of RAP to amino acids 39-53. T he design of therapies for autoimmune diseases is primarily based on identification of antigenic targets and induction of specific immune tolerance. Considerable progress has been made recently in several areas, such as allergic encephalomyelitis, in which epitopes were identified and duplicated by synthetic peptides (1, 2). However, relatively little is known about antigens ofglomerular immune complex diseases despite their tendency to cause chronic renal failure. To learn more about the molecular pathogenesis of one relatively frequent glomerular immune disease, membranous glomerulopathy (3), we have investigated in detail an established experimental model in rats, i.e., passive Heymann nephritis (pHN) 1 (4, 5). A hallmark of pHN is the presence of granular subepitheliaI immune deposits (IDs) that firmly adhere to the glomemlar basement membrane ~Abbreviations used in this paper: FxlA, crude renal cortex fraction; HN, Heymann nephritis; HNAC, HN antigenic complex; GBM, glomemlar basement membrane; ID, immune deposit; pHN, passive Heymann nephritis; PLP, paraformaldehyde-lysine-periodate; RAP, receptor-associated protein; RAPI_st, NH2-tertmna186 amino acids of RAP.
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(GBM) (6) . The goal of our analyis ofpHN is to eventually develop peptide-based therapies to specifically interfere with ID formation to provide a curative therapy for this model of membranous glomerulopathy.
In a series of investigations aimed at the identifcation of pHN antigens, we have used Abs eluted from glomeruli of diseased rats as the major tool, expecting that their specificities could guide us to the target antigen(s) and eventually to the pathogenic epitopes. This strategy led initially to identification of the >515-kD membrane glycoprotein megalin/gp330 (7, 8) and then to the 44-kD receptor-associated protein (RAP; 9, 10) formerly called C14 (11) , which are associated together to form the Heymann nephritis antigenic complex (HNAC) (9) . Search for pathogenic epitopes on HNAC has revealed one site that was originally thought to be localized on megalin (12) , but was subsequently found to reside within the 86 NH2-terminal amino acids of RAP (RAPl_86) (12) . Here, we further exploit the specificity ofeluted glomerular Abs for the precise identification of the minimal antigenic target on RAP that is sufficient and competent for the induction of stable IDs.
Materials and Methods
Antibodies. Anti-RAP Abs were prepared by intradermal immunization of rabbits with 30 txg rtLAP from the cDNA done C14, as described (11) . IgG fractions were prepared on protein A-Sepharose 4B (Pharmacia, Uppsala, Sweden) and at~nity purified further on rKAP fusion protein coupled to a cyanogen bromideSepharose 4B column (Pharmacia) (11) . Some IgG fractions were also affinity purified using a recombinant R.API_86 (12) .
Induction Of pHN and Elution of Glomerular IgG. P H N was induced by '-25 mg i.v. of anti-rRAP IgG into 200 g male Lewis rats (Charles River, Sulzfeld, Germany). Eluted IgG was prepared from the isolated glomeruli of 50 rat kidneys with 100 m M citric buffer, pH 2.8 (7), and was concentrated on protein A-Sepharose. The use of experimental animals was authorized by the Austrian Ministry of Science. 
Preparation of Immobilized Overlapping Synthetic Peptides (SPOTs Assay

Epitope Mapping by Immunoblotting on SPOTs Membranes.
SPOTs membranes were immunoblotted with affinity-purified Abs specific for RAP1-86 or with eluted glomerular IgG (11, 12) . Membranes were developed and erased before reuse according to the manufacturer's instructions (Imperial Chemical Industries).
The amino acid sequences of Ab-binding domains were deduced from the common amino acid sequence shared by all labeled spots (Fig. 1 ).
Design and Production of Synthetic Peptides. Peptides were designed, two of which were extended by several amino acids towards the NH 2 terminus of RAP beyond the region, to which eluted glomerular IgG bound in the SPOTs analysis (see Fig. 2 ). Three peptides were produced: (a) P31-53 (KAKRLHLSPVR.-LAELHSDLKIQE, amino acids 31-53); (b) P31-44 (KAKRLHL-SPVR.LAE, amino acids 31-44); and (c) P46-53 (HSDLKIQE, amino acids 46-53). As controls, the irrelevant peptides Ps5-64, P64-73, and PI16-126 from outside the antigenic regions of RAP were synthesized. Peptides were produced in an automatic peptide synthesizer (model 430A; Applied Biosystems, Inc., Foster City, CA). Peptides were purified to >95% purity by reversephase HPLC, and their sequences were analyzed in an Applied Biosystems gas phase sequencer at the Institute of Applied Microbiology, University of Agriculture (Vienna, Austria).
Preparation of Peptide-specific Abs. Synthetic peptides were coupled to a multiple antigenic peptide-polylysine matrix (13) and rabbits were immunized with 2.5 mg i.d. of each synthetic peptide, followed by two boosts with 1 mg peptide, each at 3 and 6 wk. Sera were collected at weekly intervals from the second boost onwards. IgG fractions were purified on protein A-Sepharose 4B and further affinity purified on CNBr-Sepharose coupled to the corresponding peptides (5-10 mg peptide/ml) as follows: 4 ml serum/rrd affinity adsorbent were circulated for 12 h at 4~ washed with 200 column volumes of PBS, and etuted with 20 mM gJycine-HC1 buffer, pH 2.8, 150 mM NaC1, 0.01% gelatin at 4~ Eluted IgG was neutralized with 1 M Tris-HC1 buffer, pH 8.0, dialyzed against 4 liters PBS, and concentrated with Aquacide II (Calbiochem, San Diego, CA) to 1-5 mg IgG/ml. P46-53 prepared as a multiple antigenic peptide or conjugated to KLH or BSA was not immunogenic in rabbits. P46_s3-specific IgG was therefore prepared by affinity purification of anti-RAP IgG on a P46-s3 CNBr column and used in lieu of Abs raised against the synthetic peptide.
Immunoblotting of Peptide-spedfic Antibodies. Rat kidney microvilli were prepared as described (7), and proteins were separated by SDS-PAGE and transferred onto nitrocellulose membranes.
Lysates of isopropyl [3-D-thiogalactoside (Sigma Chemical Co., St. Louis, MO)~induced Escherichia coli producing rRAP (11) were similarly transferred. Immunoblotting was performed with affinity-purified antipeptide Abs (,~10 p~g/ml) or with anti- Immunofluorescence. 3 d after injection ofpeptide-specific IgGs, direct immunofluorescence was performed on semithin 1.5-btm frozen sections of rat kidneys fixed with paraformaldehydelysine-periodate (PLP; 14) and cut on an Ultracut ultramicrotome equipped with an FC 4 cryoattachment (P, eichert, Vienna, Austria). Sections were incubated with FITC-labeled goat anti-rabbit F(ab')2 fragments (DAKO, Copenhagen, Denmark), followed by FITC rabbit anti-goat F(ab')2 (DAKO) to enhance the fluorescence signal. Micrographs were taken on an Axiophot microscope equipped for epifluorescence (Zeiss, Oberkochen, Germany).
Immunohistochemistry on Isolated Basement Membranes. Isolated GBMs
were prepared by incubation of 5-1~m unfixed cryostat sections of rat kidneys injected with anti-P3>s3 IgG with 1% Triton X-100 in PBS, followed by 4% deoxycholate in distilled water for 1-3 h at 20~ (15) . These cell-free preparations were processed for direct immunofluorescence, as described above. Localization of IDs in similar preparations was performed by immunogold electron microscopy as described (6) . Briefly, cell-free sections were quenched with 10% OVA in PBS and incubated with 1:100 diluted goat anti-rabbit IgG conjugated to 10-rim gold particles (Amersham International, Amersham, UK) for 1 h at 20~ After five washes in PBS-10% OVA, samples were fixed with 2.5% glutaraldehyde in 100 mM cacodylate buffer, pH 7.2, followed by 1% osmimn tetroxide in the same buffer and embedding in Epon 812.
Electron Microscopy. Samples of renal cortex from PLP-perfused kidneys of rats injected with anti-P31_s3 Abs were postfixed in veronal acetate-buffered osmium, stained en bloc with uranyl acetate, and processed for routine electron microscopy (6).
BLAST&arches. Online BLAST searches were performed via the National Center for Biotechnology Information at the National Institutes of Health (Bethesda, MD). PredictProtein (European Molecular Biology Laboratory, Heidelberg, Germany) was used for structural protein analysis (16) . We use the term "homology" as being identity plus conserved amino acid substitution.
Results
Anti-RAP Abs and Eluted Glomerular Abs Bind Selectively to Two Adjacent Domains of RAP. SPOTs membranes were
prepared containing the primary sequence of RAPl_86 disassembled into 72 overlapping 11-meric synthetic peptides (Fig. 1, A and B) . This permitted simultaneous screening of all peptides for Ab-binding sites by immunoblotting that was initially performed with IgG eluted from glomeruli of rats injected with rRAP-specific Abs. Eluted IgG specifically labeled two clusters of spots, one corresponding to VRLAE (amino acids 40-44) and the second to HSDLKIQE (amino acids 46-53), which were separated by an L residue at amino acid 45 (Fig. 1, B and C) . IgGs specific for rRAP and RAP1_86 yielded similar results; however, both IgGs bound also to an additional P residue at amino acid 39 (Fig.  1 C) . No labeling was observed in control experiments with irrelevant rabbit IgG or without primary Ab (data not shown).
These results indicate that the minimal binding sites on RAP of the most relevant Ab in this study, i.e., the eluted glomerular IgG, comprised a region of 14 amino acids with one intervening L residue. The accuracy of the NH2-terminal border of the first Ab-binding region was limited by variation of + 1 amino acid in repeated immunoblots on multiple SPOTs membranes.
Antipeptide Antibodies React Specifically with RAP. Two synthetic peptides were designated P31~4 and P46-53 according to their amino acid composition. P31-44 was extended beyond the binding region of eluted glomemlar IgG by nine amino acids towards the NH2 terminus of RAP to account for the variability of this border in the SPOTs assays. In addition, P31-53, which covered both binding regions of eluted IgG, was synthesized (Fig. 2) . Rabbit Abs specific for these peptides were prepared and affinity purified on CNBr peptide columns.
All antipeptide IgGs specifically and strongly reacted with RAP by immunoblotting on transfers of rRAP (Fig.  3) or on isolated microvillar fractions (Fig. 4) . On SPOTs membranes, anti-P3>44 IgG specifically labeled PVRLAE (amino acids 39--44), and anti-P46_s3 IgG bound to SDL-KIQE (amino acids 47-53). IgG raised against P31-53 bound to PVRLAELHSDLKIQE (amino acids 39-53) but not to amino acids 31-38 (Fig. 5) . In control experiments, Abs raised to peptides distant from the NH 2 terminus of RAP bound only to their respective antigenic peptides (data not shown). These data provide evidence that Abs raised against synthetic peptides selectively bound to their respective sequences on RAP and mirrored the binding sites of IgG eluted from glomeruli.
Antibodies Specific for Peptide P31-s.3 Induce IDs That Firmly
Attach to the GBM. Abs produced against peptides P31-aa and P4r failed to induce IDs at 3 and 6 d after injection into rats (data not shown). By contrast, fine granular IDs were observed in the peripheral capillary walls ofglomeruli after injection of anti-P31_s3 IgG (Fig. 6) , in a pattern typical for HN. Some IgG was also detected within the mesangium. The glomerular pattern of IDs was confirmed by • 1200. electron microscopy, which revealed small deposits primarily within clathrin-coated pits at the base of the foot processes ofpodocytes (Fig. 7) .
Unfixed kidney sections o f rats injected with anti-P31_53 IgG were extracted with detergents to remove cellular material. By direct immunofluorescence, granular IDs containing rabbit IgG were observed to adhere to the cell-free GBMs o f glomerular capillaries (Fig. 8 ) similar in size and distribution to IDs in unextracted sections. By immunoelectron microscopy o f isolated GBMs, IDs were observed in the lamina rara externa of the GBM that were specifically labeled by anti-rabbit IgG-gold conjugate (Fig. 9) .
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These results indicate that IgGs specific for P31-s3 form small IDs in peripheral glomerular capillary loops and that these IDs are firmly attached to the GBMs. Thus, this peptide-specific Ab is able to generate small IDs similar to those observed in p H N induced by IgGs specific for rRAP or RAP1_86 (11, 12) .
Predictions of Homologies and Structure of the P31-s3. P31-53 was
found to contain twice a putative R T -1 B 1 M H C class I Ibinding motif, S x x x x x E (Fig. 10) , thought to be important for generation o f Abs in Lewis rats (17) . Search for sequence similarities revealed no other significant resemblance o f P31_s3 to other rat proteins. Predictions o f second- (Fig. 11) .
Discussion
Binding of antibodies in situ to specific epitopes on H N A C , a complex of R A P and megahn/gp330 (9, 18) , triggers the formation of persistent IDs in the G B M (6) . W e and others have observed that Abs raised against r R A P form IDs after injection into rats (11, 19) . W e had previously identified a single ID-forming epitope at the NH2 terminus ofIKAP (KAP~_s6) (12) by the expression o f a series o f R A P c D N A deletion clones, raising o f specific Abs, and probing of their ability to induce glomerular IDs. Here, we precisely determine the minimal amino acid sequence on R A P I 4 6 that is required for the binding of eluted glomerular IgG by mapping of IgG-binding domain(s) on overlapping synthetic peptides. In a second step, synthetic peptides that duplicated the Ab-binding domains were produced, and specific Abs were raised and probed for their capacity to induce stable glomerular IDs.
Mapping of binding sites of etuted Abs on a large number of RAPl_86-derived synthetic peptides was performed by SPOTs assays. The results provided evidence for two adjacent Ab-binding domains within the sequences VR-L A E L H (amino acids 40--44) and HSDLKIQE (amino acids 46-53), with an apparent inaccuracy of + 1 amino acid at the NH2-terminal border of the first binding site. These findings raised the possibili W that RAP amino acids 40-53 were involved in ID formation in vivo and that appropriate peptide-specific Abs could induce IDs. At first, peptides P31-44 and P46-s3 were synthesized, and specific rabbit Abs were prepared which, however, failed to form IDs when injected into rats. Therefore, a large peptide spanning both P31~t4 and P46-53 was designed and designated P31-53-Intravenous injection of Abs raised against this peptide promptly induced small IDs in the peripheral capillary walls of glomeruli. Moreover, these IDs strongly adhered to the GBM in cell-free preparations of GBMs. Thus, in most respects, IDs produced by injection of anti-P3i_53 IgG were similar to those induced by conventional Abs (6) .
These data indicate that anti-P31_s3 IgG binds in vitro and in vivo to the same amino acid sequence of RAP as Abs eluted from glomeruli of rats with pHN. Intriguingly, Abs raised against P31--44 and P46-s3 failed to produce IDs when injected into rats. It is possible that P31-53 acts as a composite peptide that mimics a natural structural epitope by simultaneously presenting two linked antigenic peptides to the immune system. Thus, while Abs raised against the composite peptide bind in vivo to the native protein, Abs raised against individual smaller peptides bind to their respective amino acid sequences only in vitro in unfolded proteins. A similar situation was recently observed for the proliferating cell nuclear antigen in lupus erythematosus (20) . Abs specific for individual synthetic peptides modeled after immunogenic domains failed to bind in vivo. Abs raised against a dimer of these peptides, however, readily bound to their nuclear antigen in vivo, presumably because this composite peptide antigen resembled the corresponding conformation-dependent natural epitope. It remains to be seen to which extent the structural predictions of a helix-loop-helix motif in the region of the P31-s3 peptide are related to the topography of this epitope on RAP.
H N is characterized by relatively large IDs and by proteinuria. Although large amounts of Ab specific for P31-53 were injected into rats, the IDs obtained were considerably smaller than those induced by conventional Abs, such as antimegalin/gp330 IgG (6, 21) . h is possible that anti-P31_53 IgG serves only as nidus for ID formation, and that additional Abs directed against epitopes on megalin bind subsequently. We have provided evidence that antimegalin Abs without reactivity to RAP induce IDs (21) , and one epitope on megalin was recently identified on the fifth cystine-rich repeat of the second LDL receptor-like domain of megalin (22) . Thus, while the RAP epitope identified in this study provides a single nidus for the formation of an initial ID, it is clear that additional epitopes on megalin must be operative to yield IDs of the large sizes typically found in passive and active HN. Lack of proteinufia after injection of anti-P31-53 IgG is presumably caused by the absence of C5b-9-actirating Abs specific for glycolipids that were recently identified as components ofanti-FxlA IgG (23) .
In a next step, it will be of interest to attempt to produce active H N by immunization of Lewis rats with synthetic peptides, which may be facilitated by two putative MHC class II peptide--binding motifs specific for Lewis rats (17) within P31-53. Further on, attempts to interfere with the immunologic basis of the disease by use of synthetic peptides will be possible. One example indicating the feasibility of this approach is derived from studies on experimental murine interstitial nephritis (24) , which was ameliorated by specific synthetic peptides. Collectively, the results of this study provide evidence for a presumably structural epitope on RAP that is responsible for the formation of subepithelial IDs in pHN and spans 14 amino acids. These findings are also the first example of induction of glomerular IDs with Abs specific for synthetic peptides modeled after natural Ab-binding sites.
